Spinnaker Trust’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $670K | Buy |
1,505
+260
| +21% | +$116K | 0.04% | 180 |
|
|
2025
Q1 | $604K | Buy |
1,245
+10
| +0.8% | +$4.85K | 0.04% | 185 |
|
|
2024
Q4 | $497K | Buy |
1,235
+25
| +2% | +$10.1K | 0.03% | 196 |
|
|
2024
Q3 | $563K | Hold |
1,210
| – | – | 0.03% | 187 |
|
|
2024
Q2 | $567K | Hold |
1,210
| – | – | 0.04% | 186 |
|
|
2024
Q1 | $506K | Hold |
1,210
| – | – | 0.03% | 193 |
|
|
2023
Q4 | $492K | Hold |
1,210
| – | – | 0.03% | 188 |
|
|
2023
Q3 | $421K | Hold |
1,210
| – | – | 0.03% | 192 |
|
|
2023
Q2 | $426K | Hold |
1,210
| – | – | 0.03% | 186 |
|
|
2023
Q1 | $381K | Hold |
1,210
| – | – | 0.03% | 190 |
|
|
2022
Q4 | $349K | Hold |
1,210
| – | – | 0.03% | 215 |
|
|
2022
Q3 | $350K | Hold |
1,210
| – | – | 0.03% | 206 |
|
|
2022
Q2 | $341K | Sell |
1,210
-20
| -2% | -$5.64K | 0.03% | 218 |
|
|
2022
Q1 | $321K | Hold |
1,230
| – | – | 0.02% | 227 |
|
|
2021
Q4 | $270K | Hold |
1,230
| – | – | 0.02% | 248 |
|
|
2021
Q3 | $223K | Sell |
1,230
-1,400
| -53% | -$254K | 0.02% | 256 |
|
|
2021
Q2 | $530K | Hold |
2,630
| – | – | 0.04% | 183 |
|
|
2021
Q1 | $565K | Hold |
2,630
| – | – | 0.04% | 161 |
|
|
2020
Q4 | $621K | Buy |
2,630
+1,400
| +114% | +$331K | 0.05% | 149 |
|
|
2020
Q3 | $334K | Buy |
1,230
+120
| +11% | +$32.6K | 0.03% | 181 |
|
|
2020
Q2 | $322K | Hold |
1,110
| – | – | 0.03% | 183 |
|
|
2020
Q1 | $264K | Hold |
1,110
| – | – | 0.03% | 201 |
|
|
2019
Q4 | $243K | Buy |
+1,110
| New | +$243K | 0.02% | 227 |
|
|
2019
Q3 | – | Sell |
-1,110
| Closed | -$203K | – | 242 |
|
|
2019
Q2 | $203K | Sell |
1,110
-20
| -2% | -$3.66K | 0.02% | 227 |
|
|
2019
Q1 | $207K | Buy |
+1,130
| New | +$207K | 0.02% | 229 |
|
|
2018
Q4 | – | Sell |
-1,130
| Closed | -$217K | – | 235 |
|
|
2018
Q3 | $217K | Buy |
+1,130
| New | +$217K | 0.02% | 216 |
|